Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 2
1951 1
1953 2
1955 1
1956 2
1957 4
1958 1
1959 1
1960 15
1961 7
1962 9
1963 9
1964 7
1965 15
1966 13
1967 11
1968 10
1969 11
1970 12
1971 10
1972 8
1973 25
1974 14
1975 24
1976 20
1977 18
1978 19
1979 21
1980 27
1981 25
1982 24
1983 22
1984 18
1985 20
1986 29
1987 30
1988 62
1989 71
1990 76
1991 70
1992 96
1993 83
1994 82
1995 80
1996 83
1997 104
1998 101
1999 124
2000 149
2001 145
2002 158
2003 142
2004 182
2005 194
2006 180
2007 219
2008 224
2009 238
2010 265
2011 266
2012 289
2013 340
2014 369
2015 430
2016 515
2017 553
2018 615
2019 667
2020 812
2021 942
2022 419
Text availability
Article attribute
Article type
Publication date

Search Results

8,748 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: kakapour
Page 1
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C, Rello J, Sogo A. Domingo C, et al. Drugs. 2019 Nov;79(16):1729-1737. doi: 10.1007/s40265-019-01202-0. Drugs. 2019. PMID: 31584145 Review.
These results in fact show that, in undertreated GINA step 2 with only SABA as needed, ICS-LABA is more effective than SABA. ...Overall, we believe there is insufficient evidence for the systematic recommendation of as-needed ICS-LABA instead of SABA o …
These results in fact show that, in undertreated GINA step 2 with only SABA as needed, ICS-LABA is more effective than SABA
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries.
Janson C, Menzies-Gow A, Nan C, Nuevo J, Papi A, Quint JK, Quirce S, Vogelmeier CF. Janson C, et al. Adv Ther. 2020 Mar;37(3):1124-1135. doi: 10.1007/s12325-020-01233-0. Epub 2020 Jan 24. Adv Ther. 2020. PMID: 31981105 Free PMC article.
Such relief-seeking behavior has been reinforced by long-standing treatment guidelines, which until recently recommended SABA-only use for immediate symptom relief. We aimed to describe the current burden of SABA use among European individuals with asthma within the …
Such relief-seeking behavior has been reinforced by long-standing treatment guidelines, which until recently recommended SABA-only us …
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Nwaru BI, et al. Eur Respir J. 2020 Apr 16;55(4):1901872. doi: 10.1183/13993003.01872-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 31949111 Free PMC article.
SABA use was grouped into 3-5, 6-10 and 11 canisters per baseline-year. ...RESULTS: The analysis included 365 324 asthma patients (mean age 27.6 years; 55% female); average follow-up was 85.4 months. 30% overused SABA, with 21% collecting 3
SABA use was grouped into 3-5, 6-10 and 11 canisters per baseline-year. ...RESULTS: The analysis included 365 324 asthm
Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.
Kirkland SW, Vandenberghe C, Voaklander B, Nikel T, Campbell S, Rowe BH. Kirkland SW, et al. Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD001284. doi: 10.1002/14651858.CD001284.pub2. Cochrane Database Syst Rev. 2017. PMID: 28076656 Free PMC article. Review.
It is unclear, however, whether the combination of SAAC and SABA treatment is more effective in reducing hospitalisations compared to treatment with SABA alone. OBJECTIVES: To conduct an up-to-date systematic search and meta-analysis on the effectiveness of combined …
It is unclear, however, whether the combination of SAAC and SABA treatment is more effective in reducing hospitalisations compared to …
Asthma and COVID-19: In Defense of Evidence-Based SABA.
Amirav I, Newhouse MT. Amirav I, et al. J Asthma Allergy. 2020 Oct 15;13:505-508. doi: 10.2147/JAA.S279061. eCollection 2020. J Asthma Allergy. 2020. PMID: 33116658 Free PMC article.
It is regrettable to note that this attack on SABA occurs in the midst of an unprecedented demand for, and shortage of, SABA inhalers during the current COVID-19 pandemic, and the worldwide efforts to increase SABA supplies. In this commentary, we defend the …
It is regrettable to note that this attack on SABA occurs in the midst of an unprecedented demand for, and shortage of, SABA i …
Short-acting β-agonist use and its ability to predict future asthma-related outcomes.
Stanford RH, Shah MB, D'Souza AO, Dhamane AD, Schatz M. Stanford RH, et al. Ann Allergy Asthma Immunol. 2012 Dec;109(6):403-7. doi: 10.1016/j.anai.2012.08.014. Epub 2012 Oct 1. Ann Allergy Asthma Immunol. 2012. PMID: 23176877
Following the date of first asthma medication, an assessment period (3, 6, or 12 months) was used to measure SABA use. Asthma-related exacerbations were identified in the subsequent 12-month period. ...For adults, use of 2 or more SABA canisters was fo …
Following the date of first asthma medication, an assessment period (3, 6, or 12 months) was used to measure SABA use. Asthma- …
Response.
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Wand O, et al. Chest. 2019 Jun;155(6):1304. doi: 10.1016/j.chest.2019.02.013. Chest. 2019. PMID: 31174645 No abstract available.
Response.
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Wand O, et al. Chest. 2019 Apr;155(4):876-877. doi: 10.1016/j.chest.2019.01.020. Chest. 2019. PMID: 30955576 No abstract available.
SABA Reliance Questionnaire (SRQ): Identifying Patient Beliefs Underpinning Reliever Overreliance in Asthma.
Chan AHY, Katzer CB, Horne R, Haughney J, Correia de Sousa J, Williams S, Kaplan A. Chan AHY, et al. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3482-3489.e1. doi: 10.1016/j.jaip.2020.07.014. Epub 2020 Jul 20. J Allergy Clin Immunol Pract. 2020. PMID: 32702517
BACKGROUND: Patient overreliance on short-acting beta(2) agonists (SABA), with concomitant underuse of inhaled corticosteroids (ICS), is associated with poor asthma control and increased risk of asthma attacks. ...METHODS: The 5-item SABA Reliance Ques …
BACKGROUND: Patient overreliance on short-acting beta(2) agonists (SABA), with concomitant underuse of inhaled corticosteroids …
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies.
Canonica GW, Paggiaro P, Blasi F, Musarra A, Richeldi L, Rossi A, Papi A. Canonica GW, et al. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211042534. doi: 10.1177/17534666211042534. Ther Adv Respir Dis. 2021. PMID: 34587829 Free PMC article.
The risks of overusing short-acting beta(2)-agonists (SABA), including an increase in asthma-related deaths, are many and well known. ...Here, we examine the rationale for this shift from a long-standing recommendation for as-needed SABA treatment to the use …
The risks of overusing short-acting beta(2)-agonists (SABA), including an increase in asthma-related deaths, are many and well …
8,748 results